SCHEMBL5773980

SCHEMBL5773980

Cc1nc(N2CCOCC2)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.55
HSD17B10 Q99714 4/20 0.50
CASP1 P29466 1/20 0.50
CSF1R P07333 1/20 0.49
MAPT P10636 4/20 0.49
MAPK1 P28482 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
TSHR P16473 2/20 0.49
LMNA P02545 4/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
GAA P10253 2/20 0.47
HPGD P15428 3/20 0.46
AHR P35869 1/20 0.46
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 4/20 0.46
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772625 0.89 MELK (0.45) NPY5RHSD17B10MAPTMAPK1NPSR1
SCHEMBL5773349 0.89 NPY5R (0.52) NPY5RHSD17B10KMT2AKDM4EL3MBTL1
SCHEMBL5771896 0.89 NPY5R (0.52) NPY5RHSD17B10KMT2AKDM4EL3MBTL1
SCHEMBL5773681 0.88 NPY5R (0.54) NPY5RHSD17B10KMT2AHPGDKDM4E
Hydrochloric Acid SCHEMBL5773699 0.87 MELK (0.44) NPY5RHSD17B10MAPTMAPK1NPSR1
SCHEMBL5774815 0.86 NPY5R (0.54) NPY5RHSD17B10TSHRKMT2AHPGD
Hydrochloric Acid SCHEMBL5777287 0.86 NPY5R (0.50) NPY5RHSD17B10KMT2AKDM4EL3MBTL1
Hydrochloric Acid SCHEMBL5776807 0.86 NPY5R (0.50) NPY5RHSD17B10KMT2AKDM4EL3MBTL1
SCHEMBL5775329 0.84 KDM4E (0.45) NPY5RHSD17B10HPGDALDH1A1KDM4E
SCHEMBL5772277 0.84 NPY5R (0.41) NPY5RCSF1RMAPTTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed